CoChat

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Open access
Pinyol, Roser, Torrecilla, Sara, Wang, Huan, Montironi, Carla, Piqué-Gili, Marta, Torres-Martin, Miguel, Wei-Qiang, Leow, Willoughby, Catherine E., Ramadori, Pierluigi, Andreu-Oller, Carmen, Taik, Patricia, Lee, Youngmin A., Moeini, Agrin, Peix, Judit, Faure-Dupuy, Suzanne, Riedl, Tobias, Schuehle, Svenja, Oliveira, Claudia P., Alves, Venancio A., Boffetta, Paolo, Lachenmayer, Anja, Roessler, Stephanie, Minguez, Beatriz, Schirmacher, Peter, Dufour, Jean-François, Thung, Swan N., Reeves, Helen L., Carrilho, Flair J., Chang, Charissa, Uzilov, Andrew V., Heikenwalder, Mathias, Sanyal, Arun, Friedman, Scott L., Sia, Daniela, Llovet, Josep M. · 2021 · Journal of Hepatology
Cited by 247

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background and Aims: Non-alcoholic steatohepatitis (NASH)-related hepatocellular carcinoma (HCC) is increasing globally, but its molecular features are not well defined. We aimed to identify unique molecular traits characterising NASH-HCC compared to other HCC aetiologies. Methods: We collected 80 NASH-HCC and 125 NASH samples from 5 institutions. Expression array (n = 53 NASH-HCC; n = 74 NASH) and whole exome sequencing (n = 52 NASH-HCC) data were compared to HCCs of other aetiologies (n = 184). Three NASH-HCC mouse models were analysed by RNA-seq/expression-array (n = 20). Activin A receptor type 2A (ACVR2A) was silenced in HCC cells and proliferation assessed by colorimetric and colony formation assays. Results: Mutational profiling of NASH-HCC tumours revealed TERT promoter (56%), CTNNB1 (28%), TP53 (18%) and ACVR2A (10%) as the most frequently mutated genes. ACVR2A mutation rates were higher in NASH-HCC than in other HCC aetiologies (10% vs. 3%, p <0.05). In vitro, ACVR2A silencing prompted a significant increase in cell proliferation in HCC cells. We identified a novel mutational signature (MutSig-NASH-HCC) significantly associated with NASH-HCC (16% vs. 2% in viral/alcohol-HCC, p = 0.03). Tumour mutational burden was higher in non-cirrhotic than in cirrhotic NASH-HCCs (1.45 vs. 0.94 mutations/megabase; p <0.0017). Compared to other aetiologies of HCC, NASH-HCCs were enriched in bile and fatty acid signalling, oxidative stress and inflammation, and presented a higher fraction of Wnt/TGF-β proliferation subclass tumours (42% vs. 26%, p = 0.01) and a lower prevalence of the CTNNB1 subclass. Compared to other aetiologies, NASH-HCC showed a significantly higher prevalence of an immunosuppressive cancer field. In 3 murine models of NASH-HCC, key features of human NASH-HCC were preserved. Conclusions: NASH-HCCs display unique molecular features including higher rates of ACVR2A mutations and the presence of a newly identified mutational signature.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2021.04.049

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 247

Metadata

Authors
Pinyol, R., Torrecilla, S., Wang, H., Montironi, C., Piqué-Gili, M., Torres-Martin, M., Wei-Qiang, L., Willoughby, C. E., Ramadori, P., Andreu-Oller, C., Taik, P., Lee, Y. A., Moeini, A., Peix, J., Faure-Dupuy, S., Riedl, T., Schuehle, S., Oliveira, C. P., Alves, V. A., Boffetta, P., Lachenmayer, A., Roessler, S., Minguez, B., Schirmacher, P., Dufour, J.-F., Thung, S. N., Reeves, H. L., Carrilho, F. J., Chang, C., Uzilov, A. V., Heikenwalder, M., Sanyal, A., Friedman, S. L., Sia, D., & Llovet, J. M.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2021-10
Volume
75
Issue
4
Pages
865-878
ISSN
0168-8278 (ISSN-L)
OpenAlex
W3163276782
Cited by
247
References
18
FWCI
19.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. https://app.cochat.ai/papers/10.1016/j.jhep.2021.04.049
The paper
Pinyol, R., Torrecilla, S., Wang, H., Montironi, C., Piqué-Gili, M., Torres-Martin, M., Wei-Qiang, L., Willoughby, C. E., Ramadori, P., Andreu-Oller, C., Taik, P., Lee, Y. A., Moeini, A., Peix, J., Faure-Dupuy, S., Riedl, T., Schuehle, S., Oliveira, C. P., Alves, V. A., . . . Llovet, J. M. (2021). Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2021.04.049

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.